Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heyder Omran

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Thrombosis and Haemostasis|June 4, 2009
Bridging of oral anticoagulation with low-molecular-weight heparin: experience in 373 patients with renal insufficiency undergoing invasive proceduresChristoph Hammerstingl, Heyder Omran,
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 22, 2011
Perioperative bridging of chronic oral anticoagulation in patients undergoing pacemaker implantation--a study in 200 patientsChristoph Hammerstingl, Heyder Omran
Biomed Research International|November 1, 2017
Comparison of the Feasibility and Safety of First- versus Second-Generation AMPLATZER™ Occluders for Left Atrial Appendage ClosureBaravan Al-Kassou, Heyder Omran
Medizinische Klinik (Munich, Germany : 1983)|October 12, 2007
[Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients]Heyder Omran, Christoph Hammerstingl, W Dieter Paar, et al.
Thrombosis and Haemostasis|February 5, 2009
How useful is determination of anti-factor Xa activity to guide bridging therapy with enoxaparin? A pilot studyChristoph Hammerstingl, Heyder Omran, Christian Tripp, et al.
Interventional Cardiology Clinics|March 13, 2018
A History of Percutaneous Left Atrial Appendage Occlusion with the PLAATO DeviceHeyder Omran, Apostolos Tzikas, Horst Sievert, et al.
Experimental and Clinical Cardiology|July 31, 2009
D-ribose aids congestive heart failure patientsHeyder Omran, Dean McCarter, John St Cyr, et al.
Journal of Cardiovascular Electrophysiology|September 3, 2003
Mechanical occlusion of the left atrial appendageHeyder Omran, David Hardung, Harald Schmidt, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 13, 2005
Patients at high risk with atrial fibrillation: a prospective and serial follow-up during 12 months with transesophageal echocardiography and cerebral magnetic resonance imagingPeter Bernhardt, Harald Schmidt, Christoph Hammerstingl, et al.
Current Medical Research and Opinion|July 19, 2006
Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapyAlex C Spyropoulos, Rupert M Bauersachs, Heyder Omran, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Thrombosis and Haemostasis|June 4, 2009
Bridging of oral anticoagulation with low-molecular-weight heparin: experience in 373 patients with renal insufficiency undergoing invasive proceduresChristoph Hammerstingl, Heyder Omran,
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 22, 2011
Perioperative bridging of chronic oral anticoagulation in patients undergoing pacemaker implantation--a study in 200 patientsChristoph Hammerstingl, Heyder Omran
Biomed Research International|November 1, 2017
Comparison of the Feasibility and Safety of First- versus Second-Generation AMPLATZER™ Occluders for Left Atrial Appendage ClosureBaravan Al-Kassou, Heyder Omran
Medizinische Klinik (Munich, Germany : 1983)|October 12, 2007
[Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients]Heyder Omran, Christoph Hammerstingl, W Dieter Paar, et al.
Thrombosis and Haemostasis|February 5, 2009
How useful is determination of anti-factor Xa activity to guide bridging therapy with enoxaparin? A pilot studyChristoph Hammerstingl, Heyder Omran, Christian Tripp, et al.
Interventional Cardiology Clinics|March 13, 2018
A History of Percutaneous Left Atrial Appendage Occlusion with the PLAATO DeviceHeyder Omran, Apostolos Tzikas, Horst Sievert, et al.
Experimental and Clinical Cardiology|July 31, 2009
D-ribose aids congestive heart failure patientsHeyder Omran, Dean McCarter, John St Cyr, et al.
Journal of Cardiovascular Electrophysiology|September 3, 2003
Mechanical occlusion of the left atrial appendageHeyder Omran, David Hardung, Harald Schmidt, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 13, 2005
Patients at high risk with atrial fibrillation: a prospective and serial follow-up during 12 months with transesophageal echocardiography and cerebral magnetic resonance imagingPeter Bernhardt, Harald Schmidt, Christoph Hammerstingl, et al.
Current Medical Research and Opinion|July 19, 2006
Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapyAlex C Spyropoulos, Rupert M Bauersachs, Heyder Omran, et al.
Pageof 6